Biological Products, (No Diagnostic Substances) · DE · CIK 1006281
Develops and commercializes plant cell-based protein therapeutics for rare diseases, including enzyme replacement therapies
Comparable business profile · signals at a glance
In the 90 days to Dec 19, 2025: 1 insider bought $101K · 1 sold $314.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 19, 2025 | Bashan DrorPRESIDENT AND CEO | Buy | 56,000 | $1.81 | $101K |
| Nov 18, 2025 | Bar-Shalev AmosDirector | Sell | 168 | $1.87 | $314 |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.